Table 1.
Demographic characteristics among patients who completed both D14 and D28+ surveys vs only D28+ survey
| Day 14 and Day 28+ (N = 199) |
Day 28+ only (N = 212) |
Total (N = 411) |
|
|---|---|---|---|
| Sex assigned at birth | |||
| Female | 102 (51.3%) | 117 (55.2%) | 219 (53.3%) |
| Male | 97 (48.7%) | 95 (44.8%) | 192 (46.7%) |
| Age (years) | |||
| Mean (SD) | 49.1 (15.9) | 50.8 (15.5) | 50.0 (15.7) |
| Median [Min, Max] | 49.0 [16.0, 88.0] | 51.0 [18.0, 92.0] | 50.0 [16.0, 92.0] |
| Age group | |||
| < 18 | 2 (1.0%) | 0 (0%) | 2 (0.5%) |
| 18–29 | 20 (10.1%) | 19 (9.0%) | 39 (9.5%) |
| 30–39 | 38 (19.1%) | 30 (14.2%) | 68 (16.5%) |
| 40–49 | 41 (20.6%) | 43 (20.3%) | 84 (20.4%) |
| 50–59 | 48 (24.1%) | 62 (29.2%) | 110 (26.8%) |
| 60 + | 50 (25.1%) | 58 (27.4%) | 108 (26.3%) |
| Race | |||
| Non-White | 15 (7.5%) | 24 (11.3%) | 39 (9.5%) |
| White | 117 (58.8%) | 132 (62.3%) | 249 (60.6%) |
| Unknown | 67 (33.7%) | 56 (26.4%) | 123 (29.9%) |
| Ethnicity | |||
| Latino/Hispanic | 93 (46.7%) | 138 (65.1%) | 231 (56.2%) |
| Non-Latino/Hispanic | 36 (18.1%) | 30 (14.2%) | 66 (16.1%) |
| Unknown | 70 (35.2%) | 44 (20.8%) | 114 (27.7%) |
| San Diego Region | |||
| Central | 75 (37.7%) | 90 (42.5%) | 165 (40.1%) |
| East | 24 (12.1%) | 33 (15.6%) | 57 (13.9%) |
| North Central | 28 (14.1%) | 14 (6.6%) | 42 (10.2%) |
| North Coastal | 1 (0.5%) | 2 (0.9%) | 3 (0.7%) |
| North Inland | 7 (3.5%) | 4 (1.9%) | 11 (2.7%) |
| Outside County | 3 (1.5%) | 1 (0.5%) | 4 (1.0%) |
| South | 59 (29.6%) | 66 (31.1%) | 125 (30.4%) |
| Unknown | 2 (1.0%) | 2 (0.9%) | 4 (1.0%) |
| FHCSD patient status | |||
| FHCSD | 51 (25.6%) | 128 (60.4%) | 179 (43.6%) |
| Non-FHCSD | 148 (74.4%) | 84 (39.6%) | 232 (56.4%) |
| Primary care provider | |||
| FHCSD | 51 (25.6%) | 128 (60.4%) | 179 (43.6%) |
| Kaiser Permanente | 49 (24.6%) | 17 (8.0%) | 66 (16.1%) |
| Other | 73 (36.7%) | 41 (19.3%) | 114 (27.7%) |
| San Ysidro Health | 3 (1.5%) | 3 (1.4%) | 6 (1.5%) |
| Scripps | 8 (4.0%) | 12 (5.7%) | 20 (4.9%) |
| Sharp | 9 (4.5%) | 10 (4.7%) | 19 (4.6%) |
| UCSD | 1 (0.5%) | 1 (0.5%) | 2 (0.5%) |
| VA | 5 (2.5%) | 0 (0%) | 5 (1.2%) |
| Vaccination status pre-infusion | |||
| Fully vaccinated | 98 (49.2%) | 43 (20.3%) | 141 (34.3%) |
| Partially vaccinated | 1 (0.5%) | 8 (3.8%) | 9 (2.2%) |
| Unvaccinated/unknown | 100 (50.3%) | 161 (75.9%) | 261 (63.5%) |
| Language | |||
| English | 114 (57.3%) | 98 (46.2%) | 212 (51.6%) |
| Spanish | 72 (36.2%) | 103 (48.6%) | 175 (42.6%) |
| Unknown | 13 (6.5%) | 8 (3.8%) | 21 (5.1%) |
| Other | 0 (0%) | 3 (1.4%) | 3 (0.7%) |
| Day 14 and Day 28+ (N = 72) |
Day 28+ only (N = 112) |
Total (N = 184) |
|
|---|---|---|---|
| Chronic comorbiditiesa | |||
| Essential hypertension | 34 (47.2%) | 52 (46.4%) | 86 (46.7%) |
| Diabetesb | 21 (29.2%) | 34 (30.4%) | 55 (29.9%) |
| Depressive disorders | 9 (12.5%) | 27 (24.1%) | 36 (19.6%) |
| Asthma | 9 (12.5%) | 18 (16.1%) | 27 (14.7%) |
| Obesity | 11 (15.3%) | 12 (10.7%) | 23 (12.5%) |
All patients also completed the Baseline Survey
VA Veterans Affairs, SD standard deviation, FHCSD Family Health Centers of San Diego, UCSD University of California, San Diego
aChronic comorbidity data were mostly only available for internal patients, which were a minority of the study participants. Chronic comorbidities are not mutually exclusive
bIncludes type 1 diabetes and type 2 diabetes